Anesthetic Technique and Cancer Outcomes: a Meta-analysis of Total Intravenous Versus Volatile Anesthesia

Overview

Journal Can J Anaesth

Specialty Anesthesiology

Date 2019 Mar 6

PMID 30834506

Citations 89

Authors

Andrea Yap

Maria A Lopez-Olivo

Julia Dubowitz

Jonathan Hiller

Bernhard Riedel

Affiliations

Soon will be listed here.

Abstract

Purpose: Cancer-related mortality, a leading cause of death worldwide, is often the result of metastatic disease recurrence. Anesthetic techniques have varying effects on innate and cellular immunity, activation of adrenergic-inflammatory pathways, and activation of cancer-promoting cellular signaling pathways; these effects may translate into an influence of anesthetic technique on long-term cancer outcomes. To further analyze the effects of propofol (intravenous) and volatile (inhalational gas) anesthesia on cancer recurrence and survival, we undertook a systematic review with meta-analysis.

Source: Databases were searched up to 14 November 2018. Comparative studies examining the effect of inhalational volatile anesthesia and propofol-based total intravenous anesthesia (TIVA) on cancer outcomes were included. The Newcastle Ottawa Scale (NOS) was used to assess methodological quality and bias. Reported hazard ratios (HRs) were pooled and 95% confidence intervals (CIs) calculated.

Principal Findings: Ten studies were included; six studies examined the effect of anesthetic agent type on recurrence-free survival following breast, esophageal, and non-small cell lung cancer (n = 7,866). The use of TIVA was associated with improved recurrence-free survival in all cancer types (pooled HR, 0.78; 95% CI, 0.65 to 0.94; P < 0.01). Eight studies (n = 18,778) explored the effect of anesthetic agent type on overall survival, with TIVA use associated with improved overall survival (pooled HR, 0.76; 95% CI, 0.63 to 0.92; P < 0.01).

Conclusion: This meta-analysis suggests that propofol-TIVA use may be associated with improved recurrence-free survival and overall survival in patients having cancer surgery. This is especially evident where major cancer surgery was undertaken. Nevertheless, given the inherent limitations of studies included in this meta-analysis these findings necessitate prospective randomized trials to guide clinical practice.

Trial Registration: PROSPERO (CRD42018081478); registered 8 October, 2018.

Citing Articles

The effects of anaesthesia and analgesia on short- and long-term outcomes following colorectal cancer surgery: Protocol for an international, pragmatic, cohort study (ENCORE∗).

Bell M, Buggy D, Brattstrom D, Buchli C, Debouche S, Granath F Eur J Anaesthesiol Intensive Care. 2025; 3(3):e0051.

PMID: 39916820 PMC: 11798386. DOI: 10.1097/EA9.0000000000000051.

Return to intended oncological therapy following advanced ovarian cancer surgery: a narrative review.

Tse K, Chu M, Chiu J, Kwok S, Irwin M, Chan A Anaesthesia. 2025; 80 Suppl 2():106-114.

PMID: 39776385 PMC: 11744417. DOI: 10.1111/anae.16521.

Anesthetic Approaches and Their Impact on Cancer Recurrence and Metastasis: A Comprehensive Review.

Choi H, Hwang W Cancers (Basel). 2025; 16(24.

PMID: 39766169 PMC: 11674873. DOI: 10.3390/cancers16244269.

The Role of Anesthetic Management in Lung Cancer Recurrence and Metastasis: A Comprehensive Review.

Huh J, Hwang W J Clin Med. 2024; 13(22).

PMID: 39597826 PMC: 11594908. DOI: 10.3390/jcm13226681.

The Impact of Different Anesthetics on the Distribution and Cytotoxic Function of NK Cell Subpopulations: An In Vitro Study.

Vulcano T, Abdulahad W, van Meurs M, Jongman R, Struys M, Bosch D Int J Mol Sci. 2024; 25(20).

PMID: 39456827 PMC: 11507532. DOI: 10.3390/ijms252011045.

References

Sullivan R, Alatise O, Anderson B, Audisio R, Autier P, Aggarwal A . Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015; 16(11):1193-224. DOI: 10.1016/S1470-2045(15)00223-5. View

Dubowitz J, Sloan E, Riedel B . Implicating anaesthesia and the perioperative period in cancer recurrence and metastasis. Clin Exp Metastasis. 2017; 35(4):347-358. DOI: 10.1007/s10585-017-9862-x. View

Dillekas H, Demicheli R, Ardoino I, Jensen S, Biganzoli E, Straume O . The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases. Breast Cancer Res Treat. 2016; 158(1):169-178. PMC: 4937089. DOI: 10.1007/s10549-016-3857-1. View

Hiller J, Perry N, Poulogiannis G, Riedel B, Sloan E . Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol. 2017; 15(4):205-218. DOI: 10.1038/nrclinonc.2017.194. View

Ishikawa M, Tanaka S, Arai M, Genda Y, Sakamoto A . Differences in microRNA changes of healthy rat liver between sevoflurane and propofol anesthesia. Anesthesiology. 2012; 117(6):1245-52. DOI: 10.1097/ALN.0b013e3182746676. View

Sakamoto A, Imai J, Nishikawa A, Honma R, Ito E, Yanagisawa Y . Influence of inhalation anesthesia assessed by comprehensive gene expression profiling. Gene. 2005; 356:39-48. DOI: 10.1016/j.gene.2005.03.022. View

Byrne K, Levins K, Buggy D . Can anesthetic-analgesic technique during primary cancer surgery affect recurrence or metastasis?. Can J Anaesth. 2015; 63(2):184-92. DOI: 10.1007/s12630-015-0523-8. View

Soltanizadeh S, Degett T, Gogenur I . Outcomes of cancer surgery after inhalational and intravenous anesthesia: A systematic review. J Clin Anesth. 2017; 42:19-25. DOI: 10.1016/j.jclinane.2017.08.001. View

Enlund M, Berglund A, Andreasson K, Cicek C, Enlund A, Bergkvist L . The choice of anaesthetic--sevoflurane or propofol--and outcome from cancer surgery: a retrospective analysis. Ups J Med Sci. 2014; 119(3):251-61. PMC: 4116765. DOI: 10.3109/03009734.2014.922649. View

10.

Jun I, Jo J, Kim J, Chin J, Kim W, Kim H . Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: A retrospective observational study. Sci Rep. 2017; 7(1):14020. PMC: 5656640. DOI: 10.1038/s41598-017-14147-9. View

11.

Kim M, Kim D, Kim J, Lee K, Park S, Yoo Y . Does the type of anesthesia really affect the recurrence-free survival after breast cancer surgery?. Oncotarget. 2017; 8(52):90477-90487. PMC: 5685767. DOI: 10.18632/oncotarget.21014. View

12.

Lee J, Kang S, Kim Y, Kim H, Kim B . Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study. Korean J Anesthesiol. 2016; 69(2):126-32. PMC: 4823406. DOI: 10.4097/kjae.2016.69.2.126. View

13.

Wigmore T, Mohammed K, Jhanji S . Long-term Survival for Patients Undergoing Volatile versus IV Anesthesia for Cancer Surgery: A Retrospective Analysis. Anesthesiology. 2015; 124(1):69-79. DOI: 10.1097/ALN.0000000000000936. View

14.

Wu Z, Lee M, Wong C, Lu C, Huang Y, Lin K . Propofol-based Total Intravenous Anesthesia Is Associated with Better Survival Than Desflurane Anesthesia in Colon Cancer Surgery. Anesthesiology. 2018; 129(5):932-941. DOI: 10.1097/ALN.0000000000002357. View

15.

Yan T, Zhang G, Wang B, Sun L, Zheng H . Effects of propofol/remifentanil-based total intravenous anesthesia versus sevoflurane-based inhalational anesthesia on the release of VEGF-C and TGF-β and prognosis after breast cancer surgery: a prospective, randomized and controlled study. BMC Anesthesiol. 2018; 18(1):131. PMC: 6151192. DOI: 10.1186/s12871-018-0588-3. View

16.

Yoo S, Lee H, Han W, Noh D, Park S, Kim W . Total Intravenous Anesthesia versus Inhalation Anesthesia for Breast Cancer Surgery: A Retrospective Cohort Study. Anesthesiology. 2018; 130(1):31-40. DOI: 10.1097/ALN.0000000000002491. View

17.

Zheng X, Wang Y, Dong L, Zhao S, Wang L, Chen H . Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study. Onco Targets Ther. 2018; 11:1141-1148. PMC: 5840299. DOI: 10.2147/OTT.S156792. View

18.

Sessler D, Riedel B . Anesthesia and Cancer Recurrence: Context for Divergent Study Outcomes. Anesthesiology. 2018; 130(1):3-5. DOI: 10.1097/ALN.0000000000002506. View

19.

Yuki K, Bu W, Xi J, Shimaoka M, Eckenhoff R . Propofol shares the binding site with isoflurane and sevoflurane on leukocyte function-associated antigen-1. Anesth Analg. 2013; 117(4):803-811. PMC: 3844542. DOI: 10.1213/ANE.0b013e3182a00ae0. View

20.

Iwasaki M, Zhao H, Jaffer T, Unwith S, Benzonana L, Lian Q . Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells. Oncotarget. 2016; 7(18):26042-56. PMC: 5041963. DOI: 10.18632/oncotarget.8304. View